CDKN2B and central nervous system cancer: A growing number of epigenetic prognostic markers, such as ARF, CDKN2B, RB1, APC, CDH1, ESR1, GSTP1, MYOD1, and HIC1, are frequently being discovered in gliomas.14, 15